Packaging Type | Box |
Usage/Application | Hospital |
Injectable Form | Liquid |
Medicine Type | Injection |
Gender | Unisex |
Age Group | ADULT |
Shelf Life | 24 MONTHS |
Country of Origin | Made in India |
Tranexamic Acid Injection B.P. is indicated for the treatment of increased local fibrinolysis when the diagnosis is indicative of hyperfi brinolysis, as with dental extraction in patients with coagulopathies (in conjunction with antihaemophilic factor).